<DOC>
	<DOCNO>NCT01907399</DOCNO>
	<brief_summary>There link activation immune response induce chronic inflammation obesity type 2 diabetes . To date , however , cause ( ) inflammation , mechanisms inflammatory cascade type cell involve completely know . The aim project study principal cell type involve immune response quantitative functional point view obese diabetic patient versus obese non-diabetic patient healthy subject neither diabetic obese . Despite possible inter-individual heterogeneity immune cell , fact work carry accredited team considerable expertise study almost different type immune cell probably make possible know whether cell dysfunction inflammation associate obesity rather link insulin resistance . This study complete later second study cell infiltration adipose tissue 3 group define . Better understand physiopathology especially mechanisms type cell involve obesity-related inflammation could quickly lead development appropriate therapy could act specifically cell involve thus preclude onset complication .</brief_summary>
	<brief_title>Study Immune Response Obesity Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<criteria>Patientcontrol give write informed consent Patientcontrol cover National Health Insurance Agency Patientcontrol &gt; 18 year old The criterion classify patient group follow : Group 1 Obese diabetic BMI &gt; 30 Kg /m2 AND fast glycemia &gt; 1.26 g/L AND Triglycerides &gt; 1.5g/L AND HDL &lt; 0.4g/L ( men ) , &lt; 0.5g/L ( woman ) Group 2 Obese nondiabetics without metabolic syndrome BMI &gt; 30 Kg /m2 AND fast glycemia &lt; 1.10 g/L AND Triglycerides &lt; 1.5g/L AND HDL &gt; 0.4g/L ( men ) , &gt; 0.5g/L ( woman ) Group 3 Healthy Subjects BMI &lt; 25 Kg/mÂ² AND fast glycemia &lt; 1.10g/L AND Triglycerides &lt; 1.5g/L Persons cover National Health Insurance Agency Patients present recent infection , cancer patient treat corticosteroid antiinflammatory drug . Patients diabetes follow overload disease ( hemochromatosis ) due disease pancreas Chronic infection Pregnant woman Patients follow treatment ( glitazone : Actos , Avendia ; GLP1 Agonist : Byetta , Victoza ; Fibrates ) Patients present severe renal insufficiency clearance &lt; 30ml/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>obese patient</keyword>
	<keyword>obese patient type 2 diabetes</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>